MAP2K1 G276W

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

MAP2K1 G276W	Melanoma	MAP2K1 G276W	Melanoma	vemurafenib Sensitive: C3 – Early Trials vemurafenib Sensitive : C3	vemurafenib Sensitive: C3 – Early Trials vemurafenib Sensitive : C3
MAP2K1 G276W	Melanoma	MAP2K1 G276W	Melanoma	dabrafenib Sensitive: C3 – Early Trials dabrafenib Sensitive : C3	dabrafenib Sensitive: C3 – Early Trials dabrafenib Sensitive : C3

Associations